GenSight Biologics has reported recent research on how gene therapy transfer works migrating vectors from treated to control eyes.
In follow up the recent French Competent Authority granting of a Cohort Temporary Authorization for Use (“ATU de Cohorte” or ATUc) in July in 2021,… Read More »GenSight Biologics has reported recent research on how gene therapy transfer works migrating vectors from treated to control eyes.